Compare Smith & Nephew plc (SNN) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Tilray Brands Inc — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Tilray Brands Inc trades at $4.24 (market cap $524.07M). The key difference: Smith & Nephew plc is far larger — about 24.1× Tilray Brands Inc's market cap, and Smith & Nephew plc pays a 2.57% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| SNN | TLRY | |
|---|---|---|
Market Cap | $12.64B | $524.07M |
Sector | Health | Health |
52-Week High | $38.70 | $21.00 |
52-Week Low | $28.73 | $4.23 |
Enterprise Value | $15.41B | $621.22M |
Dividend Yield | 2.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
